ZEB2 Rabbit Polyclonal Antibody, Unconjugated
Artikelnummer:
BYT-ORB329735
| Artikelname: |
ZEB2 Rabbit Polyclonal Antibody, Unconjugated |
| Artikelnummer: |
BYT-ORB329735 |
| Hersteller Artikelnummer: |
orb329735 |
| Alternativnummer: |
BYT-ORB329735-100 |
| Hersteller: |
Biorbyt |
| Wirt: |
Rabbit |
| Kategorie: |
Antikörper |
| Applikation: |
IHC, WB |
| Spezies Reaktivität: |
Human |
| Immunogen: |
The immunogen is a synthetic peptide directed towards the N terminal region of human ZEB2 |
| Konjugation: |
Unconjugated |
| Alternative Synonym: |
anti KIAA0569 antibody, anti SIP-1 antibody, anti SIP1 antibody, anti SMADIP1 antibody, anti ZFHX1B antibody, anti HSPC082 antibody |
| Rabbit polyclonal antibody to ZEB2 |
| Klonalität: |
Polyclonal |
| Konzentration: |
0.5 mg/ml |
| Molekulargewicht: |
136kDa |
| NCBI: |
055610 |
| UniProt: |
O60315 |
| Puffer: |
Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose. |
| Formulierung: |
Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose. |
| Sequenz: |
Synthetic peptide located within the following region: SETDEEDKLHIAEDDGIANPLDQETSPASVPNHESSPHVSQALLPREEEE |
| Target-Kategorie: |
ZEB2 |
![]()
|
25 ug of the indicated Human whole cell extracts was loaded onto a 6-18% SDS-PAGE gel. 1 ug/mL of the antibody was used in this experiment. |
![]()
|
Sample Tissue: Human HCT116 Whole Cell, Antibody Dilution: 1 ug/mL. |
![]()
|
Sample Tissue: Human HepG2 Whole Cell, Antibody Dilution: 1 ug/mL. |
![]()
|
Sample Type: Jurkat Whole Cell, Lane A: Primary Antibody, Lane B: Primary Antibody + Blocking Peptide, Primary Antibody Concentration: 1 ug/mL, Peptide Concentration: 5 ug/mL, Lysate Quantity: 25 ug/lane/Lane, Gel Concentration: 0.12. |
![]()
|
Immunohistochemistry with Brain, cortex tissue at an antibody concentration of 5 ug/mL using anti-ZEB2 antibody (orb329735). |
![]()
|
WB Suggested Anti-ZEB2 Antibody Titration: 0.2-1 ug/mL, ELISA Titer: 1:62500, Positive Control: Jurkat cell lysate. |
